Posts in category

In Depth


Debbie Rigby takes a look at the latest in research news Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia A systematic review and network meta-analysis of 209 studies explored …

Things won’t return to the old ‘normal’, so pharmacies have to innovate and be clever to thrive as restrictions lift, say Bruce Annabel and Mal Scrymgeour When the coronavirus potentially …

Medicines are intended to prevent and treat disease and illness. Yet, in many cases, particularly those involving older Australians, medicines may be doing more harm than good As masters of …

Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …

AJP speaks to a Melbourne pharmacy professor and a student on how education and placements have been transformed during the COVID-19 pandemic The pandemic has sped up changes which may …

Debbie Rigby rounds up the latest in research news Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs A population‐based nested case–control study has shown …

What does the 7CPA mean for the pharmacy business sales market? Natalie Sirianni provides the latest update Now that we are in the new financial year, the Seventh Community Pharmacy …

We need to look out for the vulnerable, writes Louise Stone, Australian National University Metropolitan Melbourne and Mitchell Shire are beginning another six weeks of lockdown due to a spike …

Louis Roller looks at the risk factors and preventive strategies for falls Falls are a main cause of morbidity and disability in older persons. More than one-third of persons 65 years …

Calls to restrict analgesics to S3, concerns over pharmacy only range ‘leakage’, debates over advertising medicines! Welcome to July 1970 Should the advertising of pharmaceuticals to the public be stopped? …

Debbie Rigby takes a look at the latest in research news Clinical impact of antipsychotic and benzodiazepine reduction Data from the Reducing Use of Sedatives (RedUSe) project involved 150 Australian …

Will drones soon be dropping medication to our doors? Robert Read looks at a development that may revolutionise pharmacy  We’re already starting to see some exceptional examples of innovation come …